Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-08 Purchase(A) | 2023-02-17 6:40 pm | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 27,000 | $1.8929 | $51,108 | 435,514 (Indirect) | View |
| 2022-12-08 Purchase | 2022-12-12 4:25 pm | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 27,000 | $1.8929 | $51,108 | 152,000 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:12 pm | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 125,000 | $8 | $1,000,000 | 125,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-26 Option Award | 2024-06-27 08:39 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-29 09:00 am | N/A 2033-06-28 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-17 4:42 pm | N/A 2032-10-13 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 980,365 | $0 | 125,000 (Indirect) | View |
Ownership | 2021-07-26 9:20 pm | N/A 2030-12-29 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 0 | $0 | 599,576 (Direct) | View |